About Synapticure
Synapticure is a company based in Chicago (United States) founded in 2019 by Jason Langheier, Sandra Abrevaya, Martina De Majo, Brian Wallach, and Jonathan Hirsch. Synapticure has raised $46.15 million across 3 funding rounds from investors including CommonSpirit, RA Capital and B Capital. The company has 20 employees as of December 31, 2022. Synapticure offers products and services including Virtual Neurology Care and Care Coordination Services. Synapticure operates in a competitive market with competitors including Aveanna, AccentCare, Viemed, BAYADA Home Health Care and Gentiva, among others.
- Headquarter Chicago, United States
- Employees 20 as on 31 Dec, 2022
- Founders Jason Langheier, Sandra Abrevaya, Martina De Majo, Brian Wallach, Jonathan Hirsch
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Synapticure, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$46.15 M (USD)
in 3 rounds
-
Latest Funding Round
$40.15 M (USD), Series A
Sep 09, 2024
-
Investors
CommonSpirit
& 20 more
-
Employee Count
20
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Synapticure
Synapticure offers a comprehensive portfolio of products and services, including Virtual Neurology Care and Care Coordination Services.
Remote consultations for neurological conditions and treatments.
Manages referrals and insurance for patient care needs.
People of Synapticure
Unlock access to complete
Unlock access to complete
Funding Insights of Synapticure
Synapticure has successfully raised a total of $46.15M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $40.15 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Synapticure
Synapticure has secured backing from 21 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include CommonSpirit, RA Capital and B Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multistage investments are directed toward technology, healthcare, and climate sectors.
|
Locked | Locked | Locked | |
|
Venture capital investment for the healthcare industry
|
Locked | Locked | Locked | |
|
Investments are focused on neurotechnology for brain disorders.
|
Locked | Locked | Locked |
Investor details for Synapticure
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Synapticure
Investment portfolio details for Synapticure
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Synapticure
Detailed financials for Synapticure
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Synapticure Comparisons
Peer comparison for Synapticure
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Synapticure
Synapticure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aveanna, AccentCare, Viemed, BAYADA Home Health Care and Gentiva, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diversified home healthcare services are provided to patients nationwide.
|
|
| Locked | Locked | Locked |
Post-acute home health care services,
|
|
| Locked | Locked | Locked |
Home respiratory services are provided for patients with chronic diseases.
|
|
| Locked | Locked | Locked |
Full-service home health care is delivered nationwide.
|
|
| Locked | Locked | Locked |
Home hospice and palliative care services are provided nationwide.
|
Detailed competitors of Synapticure
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Synapticure
Complete news archive for Synapticure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synapticure
Synapticure was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Synapticure is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Sandra Abrevaya is the current CEO of Synapticure. They have also founded this company.
Synapticure is a funded company, having raised a total of $46.15M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Synapticure is 20.
Synapticure was established in 2019 in Chicago, United States, as a provider of home healthcare services. Operations are conducted within the healthcare sector, where medical care is delivered directly to patients homes. Services encompass support for various health needs, with a focus on accessibility and convenience. The company operates primarily in the United States, addressing gaps in traditional healthcare delivery through remote and in-home solutions.
Synapticure's top competitors include Aveanna, Viemed and BAYADA Home Health Care.
Synapticure offers Virtual Neurology Care and Care Coordination Services.
Synapticure has 21 investors. Key investors include CommonSpirit, RA Capital, B Capital, CVS Health Ventures, and Nexus NeuroTech Ventures.